Related references
Note: Only part of the references are listed.Natural Killer T Cells and Autoimmune Disease
Lan Wu et al.
CURRENT MOLECULAR MEDICINE (2009)
Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells
Xiangming Li et al.
IMMUNOLOGY (2009)
Methods for Predicting In Vivo Pharmacokinetics Using Data from In Vitro Assays
J. Brian Houston et al.
CURRENT DRUG METABOLISM (2008)
Methods for detection, isolation and culture of mouse and human invariant NKT cells
Hiroshi Watarai et al.
NATURE PROTOCOLS (2008)
CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor
Natalie A. Borg et al.
NATURE (2007)
The length of lipids bound to human CD1d molecules modulates the affinity threshold of NKT cell activation
Corinna McCarthy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A modified α-galactosyl ceramide for staining and stimulating natural killer T cells
Yang Liu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Preferential Th2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo
S Oki et al.
INTERNATIONAL IMMUNOLOGY (2005)
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor
DM Zajonc et al.
NATURE IMMUNOLOGY (2005)
The crystal structure of human CD1d with and without α-galactosylceramide
M Koch et al.
NATURE IMMUNOLOGY (2005)
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
S Oki et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection
M Brigl et al.
NATURE IMMUNOLOGY (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Janus-like role of regulatory inkt cells in autoimmune disease and tumour immunity
SB Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide
J Schmieg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Peptide-β2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes
TF Greten et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex
S Sidobre et al.
JOURNAL OF IMMUNOLOGY (2002)
Distinct functional lineages of human Vα-24 natural killer T cells
PT Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways
Y Hayakawa et al.
JOURNAL OF IMMUNOLOGY (2001)